MYOV News

Six IPOs raised $2.3 billion this past week, including the year's largest US offering, China's logistics giant ZTO Express. ZTO priced above the range and proceeded to drop 15% on its first day, highly unusual given its pricing premium, size and origin. In fact, all four of this week's broken IPOs raised more proceeds than expected. The IPO market's one bright spot...read more

Myovant Sciences, a newly-formed biotech developing an acquired therapy for endocrine disorders, raised $218 million by offering 14.5 million shares at $15, the high end of the range of $12 to $15. Myovant Sciences plans to list on the NYSE under the symbol MYOV. Citi, Cowen & Company, Evercore ISI and Barclays acted as lead managers on the deal. Parent company Roivant...read more

Six companies are on the US IPO calendar to raise $2.2 billion in the week ahead, or $2.6 billion including a large SPAC. October is set to surpass September as the year's most active month for IPOs. Filing activity has slowed heading into November, as expected.

• ...read more

Three IPOs raised $495 million this week, led by iRhythm Technologies (IRTC), which popped 53% on its first day. The other two IPOs, CRISPR Therapeutics (CRSP) and Forterra (FRTA), priced below the range and closed the week down 1% and 6%, respectively. Forterra’s 8% drop on its first day was the eighth worst...read more